Masiha Medica Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 11-12-2024
- Paid Up Capital ₹ 0.62 M
as on 11-12-2024
- Company Age 39 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.00 Cr
as on 11-12-2024
- Satisfied Charges ₹ 5.70 M
as on 11-12-2024
- Revenue 51.19%
(FY 2023)
- Profit -35.18%
(FY 2023)
- Ebitda -47.48%
(FY 2023)
- Net Worth 7.66%
(FY 2023)
- Total Assets 86.32%
(FY 2023)
About Masiha Medica
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.62 M.
The company currently has active open charges totaling ₹8.00 Cr. The company has closed loans amounting to ₹5.70 M, as per Ministry of Corporate Affairs (MCA) records.
Sahir Khatib and Shaaz Khatib serve as directors at the Company.
- CIN/LLPIN
U24239MH1985PTC036869
- Company No.
036869
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jul 1985
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Masiha Medica?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sahir Khatib  | Managing Director | 17-Aug-1995 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shaaz Khatib | Director | 15-Dec-2021 | Current |
Financial Performance of Masiha Medica.
Masiha Medica Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 51.19% increase. The company also saw a substantial fall in profitability, with a 35.18% decrease in profit. The company's net worth moved up by a moderate rise of 7.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Masiha Medica?
In 2023, Masiha Medica had a public holding of 27.37%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Andhra Bank Creation Date: 19 Aug 1986 | ₹8.00 Cr | Open |
State Bank Of Hyderabad Creation Date: 20 Apr 1992 | ₹3.30 M | Satisfied |
State Bank Of Hyderabad Creation Date: 01 Jan 1987 | ₹0.50 M | Satisfied |
How Many Employees Work at Masiha Medica?
Unlock and access historical data on people associated with Masiha Medica, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Masiha Medica, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Masiha Medica's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
